Cita APA

Bahng, H. H., Green, S., Lai, A., Hu, J., Green, R., Iwamoto, F., . . . Nghiemphu, P. (2017). ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro Oncol.

Citación estilo Chicago

Bahng, Hye Hyun, Stacey Green, Albert Lai, Jethro Hu, Richard Green, Fabio Iwamoto, Andrew B. Lassman, Timothy Cloughesy, and Phioanh Nghiemphu. "ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA." Neuro Oncol 2017.

Cita MLA

Bahng, Hye Hyun, et al. "ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA." Neuro Oncol 2017.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.